Fortress Biotech
FBIO
50 hedge funds and large institutions have $6.43M invested in Fortress Biotech in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 5 closing their positions.
109% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 11
24% more call options, than puts
Call options by funds: $92K | Put options by funds: $74K
3% more capital invested
Capital invested by funds: $6.21M → $6.43M (+$213K)
0% more funds holding
Funds holding: 50 → 50 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
1.16% less ownership
Funds ownership: 17.76% → 16.6% (-1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$886K |
| 2 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$415K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$391K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
| 5 |
Renaissance Technologies
New York
|
+$149K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$216K |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$207K |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$200K |
| 4 |
Millennium Management
New York
|
-$91.4K |
| 5 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
-$85.7K |
FBIO Hedge Fund Activity: Q3 2024 in Review
50 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2024, worth a combined $6.43M — up 3.4% from $6.21M a quarter earlier.
Fund positioning in FBIO was balanced in Q3 2024: 5 funds opened new positions, 5 closed out, 23 added to existing stakes and 11 trimmed.
The largest buyer was Cambridge Investment Research Advisors, adding an estimated $886K. The largest seller was GSA Capital Partners, cutting an estimated $216K.
- 50 institutional investors held Fortress Biotech (FBIO) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $6.43M of Fortress Biotech stock for Q3 2024, up 3.4% quarter-over-quarter.
- 5 funds opened new Fortress Biotech positions in Q3 2024 and 5 closed out, a net change of 0 holders.
- The largest Fortress Biotech buyer in Q3 2024 was Cambridge Investment Research Advisors, an estimated $886K added.
- The largest Fortress Biotech seller in Q3 2024 was GSA Capital Partners, an estimated $216K sold.
Based on aggregated 13F filings for Q3 2024.